Purio, Inc. (OTCBB: PURO) Closed at $0.10. Today announced that it is in the final stages of setting up its first commercial outlet in Southern California. The mandate of the division DBA UltraSafe Water Source(TM) is to serve the growing number of business offices that wish to eliminate bottled water, aim to cut costs, eliminate the 5-gallon bottles from their operations, and do so with nothing to buy.
Daryl English, President of Purio, says, "North America is in the infancy of a major paradigm shift in the way business offices supply purified drinking water to their staffs and clients. We see it as a major up-coming trend and we see ourselves in a great position to profit from it. Businesses are motivated in many ways to take action and upgrade their office water service from bottle-style dispensers to modern point-of-use (POU) water purifiers and totally do away with bottled water delivery. The first motivation is cost cutting and we can often cut the monthly water budget by over 25%. Second is the convenience factor; by eliminating the plastic 5-gallon bottles, offices free up precious floor and storage space, and eliminate the risk of employee injury caused by the lifting of the 45 pound back-breakers. Our POU purifiers not only offer a fresher tasting, better quality water, compared to bottles because it's not stored in plastic for weeks before consumption, but they also offer a greater production capacity so that businesses never more worry about running out of purified water. Couple that with the environmental care factor, whereby business can update their water service from the energy hungry, labor intensive and carbon producing delivery system of old fashioned bottles, and we are of the opinion that we are on the leading edge of a business boom."
Mr. English cited cities like San Francisco, Chicago and Vancouver, British Columbia as examples of municipalities that have banned the use of bottled water in their facilities due to concerns over its affect on the environment as well as concerns about possible health risks recently revealed from studies of chemicals leaching from water bottles into the drinking water.
What They Do: Purio owns proprietary water clarification technology suitable to a broad number of applications including the clarification of surface water, industrial process water and sewage. Purio intends to apply its technology initially to industrial and commercial applications to reclaim water and reduce the need for fresh water in such applications. Purio further intends to use its proprietary technology to produce potable water for commercial and residential use. Purio will commercialize its technology via a number of channels, namely licensing strategic partners to build and sell &/or operate units outside of North America, outright sale of their second generation (patent pending) units to end users and will build, own and operate on a fee for service basis their larger permanent installation units in North America.
How They Trade: PURO has a 52 week high of $0.89 and a 52 week low of $0.05.
Glowpoint, Inc. (OTCBB: GLOW) Closed at $0.29. Today announced financial results for the three and nine month periods ended September 30, 2008. Core revenue subscription services increased 11.8% for the third quarter 2008 and 13.8% for the nine months ending September 2008. Multi-Point conferencing services increased 15.1% for the third quarter 2008 and 18.1% for the nine months ending September 30, 2008. Gross margin for the third quarter of 2008 increased 800 basis points to 40.2% from 32.2% in third quarter 2007 and 990 basis points to 42.0% from 32.1% in the nine months ending September 30, 2007. Loss from operations decreased 27.1% to $0.6 million from a loss of $0.9 million in the third quarter of 2007 and 55.4% to $1.5 million from $3.3 million in the nine months ended September 30, 2007.
Michael Brandofino, chief executive officer of Glowpoint, commented, “Economic and environmental issues are driving requirements for increased productivity and global competitive advantages. Our managed video services and custom-developed applications are becoming recognized as a critical component to solutions being demanded by enterprises, equipment manufacturers, and global carriers to address these requirements.
What They Do: Glowpoint is a premiere, IP-based managed video communications services provider. Glowpoint is innovating video communications with services supporting traditional video conferencing, Telepresence VNOC, Broadcast Content Acquisition and Delivery, and Call Center Applications. Glowpoint’s services are delivered over a robust, video-centric network that reaches around the world and serves clients ranging from Fortune 100 enterprises and leading broadcast networks to SMB markets.
How They Trade: GLOW has a 52 week high of $0.71 and a 52 week low of $0.26.
Clearant, Inc. (OTCBB: CLRA) Closed at $0.11. Today announced that preliminary revenues for the nine months ending September 30, 2008 increased 88% to $1.43 million compared to $0.76 million for the nine months ending September 30, 2007.
Preliminary direct distribution revenue grew to a record $1.18 million for the first nine months of 2008, compared to $0.44 million for the first nine months of 2007, a 169% increase. Preliminary revenues from licensing, fee for service, and contract research activities which the Company intends to de-emphasize in the future, decreased to $248,000 for the first nine months of 2008 from $323,000 for the first nine months of 2007.
Preliminary revenues for the 3rd quarter ending September 30, 2008 increased 189% to $0.46 million compared to $0.16 million in the 3rd quarter 2007.
What They Do: Clearant, Inc. is a leader in pathogen inactivation for biological products. Clearant has developed the patent-protected Clearant Process, which substantially reduces all types of bacteria and viruses in biological products while maintaining the functionality of the underlying tissue implant or protein.
How They Trade: CLRA has a 52 week high of $1.10 and a 52 week low of $0.06.
Aradigm Corporation (Pinksheets: ARDM) Closed at $0.34. Today announced financial results for the third quarter and nine months ended September 30, 2008.
Revenue for the third quarter was $197,000, compared with revenue of $230,000 for the third quarter of 2007. Revenue in the third quarter of 2008 was primarily the result of expense reimbursement from a third party for the evaluation of the delivery of certain compounds using the AERx(R) delivery system.
Total operating expenses for the third quarter of 2008 were $4.8 million, compared with total operating expenses of $7.7 million for the third quarter 2007. The decrease in operating expenses was primarily due to $2.1 million of restructuring charges recorded in the third quarter of 2007, as well as decreased research and development activity associated with the Company's lead product candidates, ARD-3100 (inhaled liposomal ciprofloxacin for the treatment of cystic fibrosis) and ARD-3150 (inhaled liposomal ciprofloxacin for the treatment of bronchiectasis). The Company's net loss for the third quarter of 2008 was $4.6 million, or $0.08 per share, compared with a net loss of $6.9 million, or $0.13 per share, for the same period in 2007.
As of September 30, 2008, cash and cash equivalents totaled $21.3 million.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com has been a leading site for news on small-cap stocks since 1999. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select small-cap stocks, to register and automatically be entered to win a Free Blackberry Pearl visit http://www.smallcapreview.com/subscribe.htm. SmallCapReview has been compensated three thousand five hundred dollars by a third party GMarketing for its efforts in presenting the Purio Inc. profile.
